1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Multivariate analysis of clinical and combined clinical and radiologic variables associated with FHP
Variables OR 95% CI Clinical predictors of FHP in MVA Admission NIHSS score 1.12 1.08–1.16 Visual field defects on admission 7.79 4.51–13.45 Aphasia at admission 2.03 1.37–3.00 Hemineglect at admission 4.50 2.46–8.22 Sensory deficit at admission 1.39 1.00–1.93 Decreased level of consciousness 6.32 2.49–16 Posterior circulation stroke 0.32 0.22–0.47 Lacunar stroke mechanism 0.14 0.08–0.24 Anticoagulation before stroke onset 0.45 0.28–0.72 Clinical and radiologic predictors of FHP in MVA Symptom onset-to-CT delay 0.97 0.95–0.99 Visual field defect at admission 6.09 3.43–10.81 Hemineglect at admission 4.13 2.06–8.27 Sensory deficit at admission 1.53 1.07–2.17 Cardioembolic stroke mechanism 1.87 1.11–3.13 Lacunar stroke mechanism 0.45 0.24–0.85 Early ischemic changes on CT 4.68 2.73–8.04 Chronic CT lesions (old strokes or leukoaraiosis) 0.54 0.33–0.87 Anterior circulation stroke 3.13 2.13–4.55 Arterial stenosis or occlusion in ischemic territory 2.29 1.32–3.99